by DB Insurance | Oct 31, 2019 | UncategorizedPfizer Inc’s rheumatoid arthritis drug Xeljanz could increase the risk of blood clots in the lungs and in deep veins, the European Medicines Agency (EMA) said on Thursday.
by DB Insurance | Oct 30, 2019 | UncategorizedThe U.S. Food and Drug Administration on Wednesday approved Biogen Inc’s new oral drug to treat multiple sclerosis, offering the drugmaker some relief as its core franchise faces patent challenges.
by DB Insurance | Oct 29, 2019 | UncategorizedOlder women who drink more soda may be more likely to suffer hip fractures than their counterparts who consume little to no soda, a recent study suggests.
by DB Insurance | Oct 28, 2019 | Uncategorized(Reuters Health) – When women visit travel medicine clinics before a trip, analysis of their pre-journey health needs often doesn’t cover contraception options and availability, a new paper warns.
by DB Insurance | Oct 26, 2019 | UncategorizedFacing off against a plaintiff’s lawyer for the first time about Johnson & Johnson’s Baby Powder, the company’s Chief Executive Alex Gorsky earlier this month insisted that the company’s iconic brand was safe.